Search Results - C.L. Novis

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent by A. Macedo, C.M. Assis, C.L. Novis, A. Spivak, V. Planelles, A. Bosque

Connect to this object online.

Ingenol derivatives are potent reactivators of latent HIV by V. Planelles, A.M. Spivak, E.T. Larragoite, C.L. Novis, L.J. Martins A. Bosque

Connect to this object online.

Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV by A.B. Macedo, C.L. Novis, A.M. Spivak, V. Planelles, J. Szu-han Huang, Y. Ren, R. Brad Jones, A. Bosque

Connect to this object online.

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 by A. Bosque, A. Macedo, A. Spivak, C.L. Novis, L.J. Martins, M. Szaniawski, N.M. Archin, P.A. Luciw, D.M. Margolis, V. Planelles

Connect to this object online.

Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells by C.L. Novis, I. Sarabia, A.B. Macedo, R. Nell, B. Shakya, H.L. Schubert, C.P. Hill, A.B. De Paula-Silva, A.M. Spivak, V. Planelles, A. Bosque

Connect to this object online.